208 related articles for article (PubMed ID: 22465309)
1. Exendin-4 decreases amphetamine-induced locomotor activity.
Erreger K; Davis AR; Poe AM; Greig NH; Stanwood GD; Galli A
Physiol Behav; 2012 Jun; 106(4):574-8. PubMed ID: 22465309
[TBL] [Abstract][Full Text] [Related]
2. The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.
Egecioglu E; Engel JA; Jerlhag E
PLoS One; 2013; 8(7):e69010. PubMed ID: 23874851
[TBL] [Abstract][Full Text] [Related]
3. Lithium normalizes amphetamine-induced changes in striatal FoxO1 phosphorylation and behaviors in rats.
Zheng W; Zeng Z; Bhardwaj SK; Jamali S; Srivastava LK
Neuroreport; 2013 Jul; 24(10):560-5. PubMed ID: 23652158
[TBL] [Abstract][Full Text] [Related]
4. The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice.
Egecioglu E; Engel JA; Jerlhag E
PLoS One; 2013; 8(10):e77284. PubMed ID: 24204788
[TBL] [Abstract][Full Text] [Related]
5. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
[TBL] [Abstract][Full Text] [Related]
6. Central & peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors.
Sirohi S; Schurdak JD; Seeley RJ; Benoit SC; Davis JF
Physiol Behav; 2016 Jul; 161():140-144. PubMed ID: 27072507
[TBL] [Abstract][Full Text] [Related]
7. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling.
Mietlicki-Baase EG; Ortinski PI; Reiner DJ; Sinon CG; McCutcheon JE; Pierce RC; Roitman MF; Hayes MR
J Neurosci; 2014 May; 34(20):6985-92. PubMed ID: 24828651
[TBL] [Abstract][Full Text] [Related]
9. Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation.
Mathes CM; Bueter M; Smith KR; Lutz TA; le Roux CW; Spector AC
Am J Physiol Regul Integr Comp Physiol; 2012 Mar; 302(6):R751-67. PubMed ID: 22170618
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.
McKay NJ; Kanoski SE; Hayes MR; Daniels D
Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1755-64. PubMed ID: 21975647
[TBL] [Abstract][Full Text] [Related]
11. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
12. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents.
Vallöf D; Kalafateli AL; Jerlhag E
Psychoneuroendocrinology; 2019 May; 103():284-295. PubMed ID: 30771711
[TBL] [Abstract][Full Text] [Related]
13. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation.
Hayes MR; Skibicka KP; Grill HJ
Endocrinology; 2008 Aug; 149(8):4059-68. PubMed ID: 18420740
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.
Yamamoto H; Kishi T; Lee CE; Choi BJ; Fang H; Hollenberg AN; Drucker DJ; Elmquist JK
J Neurosci; 2003 Apr; 23(7):2939-46. PubMed ID: 12684481
[TBL] [Abstract][Full Text] [Related]
15. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
[TBL] [Abstract][Full Text] [Related]
16. Role of lateral septum glucagon-like peptide 1 receptors in food intake.
Terrill SJ; Jackson CM; Greene HE; Lilly N; Maske CB; Vallejo S; Williams DL
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R124-32. PubMed ID: 27194565
[TBL] [Abstract][Full Text] [Related]
17. The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents.
Egecioglu E; Steensland P; Fredriksson I; Feltmann K; Engel JA; Jerlhag E
Psychoneuroendocrinology; 2013 Aug; 38(8):1259-70. PubMed ID: 23219472
[TBL] [Abstract][Full Text] [Related]
18. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
[TBL] [Abstract][Full Text] [Related]
19. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner.
Zhao S; Kanoski SE; Yan J; Grill HJ; Hayes MR
Int J Obes (Lond); 2012 Dec; 36(12):1522-8. PubMed ID: 22249232
[TBL] [Abstract][Full Text] [Related]
20. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Burmeister MA; Ayala J; Drucker DJ; Ayala JE
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
